08048036315
Leading Indian Pharma Exporter of WEGOVY FLEX 1mg Injection to Singapore – Tampines | Phoenix Exim

1. General Information

Wegovy FlexTouch 1 mg contains semaglutide 1 mg per dose. It is administered by subcutaneous injection once weekly according to the prescribed treatment schedule. Wegovy is used together with a reduced-calorie diet and increased physical activity for appropriate patients requiring weight management.

The FlexTouch 1 mg pen contains four doses and is supplied as a pre-filled injection pen.

2. Product Information

  • Brand: Wegovy FlexTouch
  • Active ingredient: Semaglutide
  • Strength: 1 mg per dose
  • Dosage form: Solution for injection
  • Route: Subcutaneous injection
  • Device: Pre-filled FlexTouch pen
  • Doses per pen: 4 doses
  • Active ingredient classification: GLP-1 receptor agonist
  • Storage: Follow the product-specific storage instructions and keep the medicine refrigerated as directed; do not freeze.

3. Uses of WEGOVY FlexTouch 1 mg

Wegovy is used as part of a weight-management program for eligible patients. Depending on the applicable country's approved labeling, indications include:

  • Weight management in adults with obesity.
  • Weight management in adults who are overweight with at least one weight-related health condition.
  • Weight management in adolescents aged 12 years and older with obesity.
  • In certain approved populations, reduction of cardiovascular risk in adults with established cardiovascular disease and overweight or obesity.

The medicine should be combined with appropriate dietary changes and physical activity rather than used as a standalone weight-loss treatment.

4. Benefits of This Medicine

Potential benefits of semaglutide treatment in appropriately selected patients include:

  • Helps reduce appetite and food cravings.
  • Promotes a feeling of fullness after eating.
  • Supports reduction of calorie intake.
  • Helps reduce excess body weight when combined with diet and physical activity.
  • Can help maintain weight reduction with continued treatment.
  • In specific approved patients, can reduce the risk of certain major cardiovascular events.

Results vary between individuals, and treatment should be monitored by a healthcare professional.

5. Side Effects of WEGOVY FlexTouch 1 mg

Like all medicines, Wegovy can cause side effects. Gastrointestinal reactions are particularly common.

Potential adverse effects include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Abdominal pain
  • Headache
  • Fatigue
  • Indigestion
  • Dizziness
  • Bloating

More serious reactions can occur, including pancreatitis, gallbladder disease, dehydration-related kidney problems, and serious allergic reactions. The prescribing information also contains a boxed warning concerning thyroid C-cell tumors observed in rodents.

6. Common Side Effects

The commonly reported side effects include:

  1. Nausea
  2. Diarrhea
  3. Vomiting
  4. Constipation
  5. Abdominal discomfort or pain
  6. Headache
  7. Fatigue
  8. Bloating
  9. Indigestion

These effects may be more noticeable when treatment is being started or the dose is being increased. Patients should contact their healthcare professional if side effects are persistent or severe.

7. How to Use WEGOVY FlexTouch 1 mg

Wegovy FlexTouch is generally administered once weekly by subcutaneous injection, on the same day each week, according to the dose prescribed by the healthcare professional.

General instructions include:

  • Check the pen label and confirm that it is the prescribed strength.
  • Use a new compatible disposable needle for each injection.
  • Inject subcutaneously into an appropriate injection site such as the abdomen, thigh, or upper arm, following professional instructions.
  • Do not inject into a vein or muscle.
  • Dispose of used needles safely.
  • Do not change the dose or injection schedule without medical advice.

The FlexTouch pen is designed to deliver four prescribed doses. Patients should carefully follow the official instructions supplied with the pen.

8. How WEGOVY Works

Semaglutide mimics the action of GLP-1, a naturally occurring hormone involved in appetite regulation.

It acts on GLP-1 receptors, including receptors involved in appetite control in the brain. This can increase feelings of fullness, reduce hunger and cravings, and consequently help reduce food intake and body weight.

9. Safety Advice

  • Use Wegovy only under the supervision of a qualified healthcare professional.
  • Do not use it if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use it if you have a known serious allergy to semaglutide or its ingredients.
  • Inform your doctor about all medicines you take, particularly insulin or medicines that increase insulin secretion, because of the risk of hypoglycemia.
  • Seek medical attention for severe or persistent abdominal pain, particularly if it may indicate pancreatitis.
  • Tell your healthcare professional if you develop symptoms suggesting gallbladder disease.
  • Maintain adequate fluid intake, particularly if vomiting or diarrhea occurs.
  • Discuss pregnancy and breastfeeding with your doctor before using semaglutide.
  • Store the product according to the official labeling and do not freeze it.

10. Frequently Asked Questions

Q1. What is WEGOVY FlexTouch 1 mg?
It is a prescription injectable medicine containing semaglutide, a GLP-1 receptor agonist used as part of an appropriate weight-management program.

Q2. How often is Wegovy injected?
Wegovy is administered once weekly according to the prescribed treatment regimen.

Q3. Can Wegovy be used without diet and exercise?
It is intended to be used together with a reduced-calorie diet and increased physical activity.

Q4. Does the 1 mg FlexTouch pen contain multiple doses?
Yes. The FlexTouch 1 mg pen contains four doses.

Q5. What is the active ingredient?
The active ingredient is semaglutide.

Q6. Is Wegovy available by prescription?
Yes. Wegovy FlexTouch is a prescription medicine.

Q7. What are the most common side effects?
Nausea, diarrhea, vomiting, constipation and abdominal symptoms are among the commonly reported adverse effects.

Q8. How should Wegovy be stored?
Storage requirements depend on the market and product labeling. The medicine generally requires refrigeration before use and must not be frozen. Follow the storage instructions supplied with the specific product.

11. Substitutes for WEGOVY FlexTouch 1 mg

Potential alternatives containing semaglutide or other GLP-1 receptor agonists may exist, but they are not automatically interchangeable with Wegovy.

Examples that a healthcare professional may consider, depending on the patient's indication and country-specific approval, include:

  • Semaglutide products
  • Liraglutide
  • Tirzepatide
  • Other approved GLP-1/GIP-based therapies

The appropriate alternative depends on the patient's medical condition, treatment goal, existing medicines, contraindications and local regulatory approval. A doctor should select the substitute rather than changing treatment independently.

12. SEO Keywords

  • WEGOVY FlexTouch 1 mg Injection exporter from India
  • WEGOVY 1 mg Injection supplier from Nagpur India
  • WEGOVY FlexTouch 1 mg wholesale supplier
  • WEGOVY 1 mg semaglutide injection exporter
  • Semaglutide 1 mg injection pharmaceutical exporter India
  • WEGOVY FlexTouch 1 mg medicine supplier
  • WEGOVY 1 mg prefilled pen exporter India
  • Genuine WEGOVY FlexTouch 1 mg supplier
  • WEGOVY 1 mg injection international pharmaceutical supplier
  • Semaglutide injection exporter from Nagpur
  • WEGOVY FlexTouch supplier USA
  • WEGOVY 1 mg supplier UK
  • WEGOVY 1 mg exporter Australia
  • WEGOVY 1 mg pharmaceutical supplier Singapore
  • WEGOVY 1 mg supplier Canada
  • WEGOVY FlexTouch supplier South Korea
  • WEGOVY 1 mg medicine supplier UAE
  • Phoenix Exim WEGOVY exporter India
  • WEGOVY FlexTouch 1 mg wholesale pharmaceutical supplier
  • Semaglutide medicine exporter India
Aug 21st, 2026 12:51 PM

Keywords